Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/13/18 → 3/5/20 |
Funding
- AbbVie Incorporated: $74,414.00
M15-738: A Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of 24-Hour and 72-Hour Subcutaneous Infusions of ABBV-951 in Subjects with Parkinson's Disease
- Slevin, John (PI)